BridgeBio Pharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $430.8M | $-870.4M | $393.8M |
| FY2022 | $431.0M | $-1.25B | $376.7M |
| FY2023 | $446.4M | $-1.35B | $375.9M |
| FY2024 | $437.3M | $-1.47B | $681.1M |
| FY2025 | $2.01B | $-2.09B | $570.1M |